{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-034610","form_type":"8-K","ticker":"FTLF","cik":"0001374328","company_name":"FITLIFE BRANDS, INC.","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.250435+00:00","generated_at":"2026-05-16T20:13:03.091557+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"confidence":"high","headline":"FitLife Q3 revenue $23.5M (+47% YoY), net income $0.9M (-57%) on acquisition costs","bullets":["Revenue $23.5M, up 47% YoY; Irwin Naturals contributed $6.8M of the $7.5M increase.","Net income $0.9M ($0.10 basic EPS) vs $2.1M ($0.23) in Q3 2024, due to Irwin transaction costs and lower gross margin.","Adjusted EBITDA $3.8M, up 6% YoY; gross margin 37.2% vs 43.8% (38.9% ex inventory step-up).","Wholesale revenue +156% to $13.2M; online -5% to $10.3M with MRC traffic decline cited.","MusclePharm wholesale +112%; MRC challenged; CEO notes rising whey protein costs and consumer weakness."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-034610","json":"https://secwatch.observer/filing/0001437749-25-034610.json","markdown":"https://secwatch.observer/filing/0001437749-25-034610.md","text":"https://secwatch.observer/filing/0001437749-25-034610.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374328/000143774925034610/0001437749-25-034610-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374328/000143774925034610/ftlf20251113_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:13:03.091557+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}